{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:31:13Z","timestamp":1793320273989,"version":"4.5.0"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>It is widely known that pneumonia (either community acquired or hospital acquired, as like ventilator associated pneumonia (VAP)), is the most frequent type of severe infection and continues to pose a significant burden on healthcare services worldwide. Despite new diagnostic developments, most pneumonia cases continue to be difficult to diagnose clinically, partly due to acquired antibiotic resistance and the lack of a \u2018gold standard\u2019 method of diagnosis. In other words, the lack of a rapid, accurate diagnostic test, as well as the uncertainty of the initial etiologic diagnosis and the risk stratification, results in empirical antibiotic treatments. There are significant changes in the aetiology of patients with ventilator associated lower respiratory tract infections (VA-LRTI), which are characterised by a higher incidence of multi drug resistant organisms. Evidence suggests that when patients with VA-LRTI develop organ failure, the associated mortality can be exceptionally high with frequent complications, including acute respiratory distress syndrome, acute kidney injury, and septic shock. Appropriate antibiotic treatments must consider that the present cardiovascular failure seen in patients has a different association with the patient\u2019s mortality. Unlike patients with less severe clinical presentations, who have a higher chance of survival when the appropriate antibiotics are administered promptly, for patients with a severe subtype of the disease, the appropriateness of antibiotic treatment will impact the patient\u2019s outcome to a lesser extent. The present review highlights certain factors detectable at the time of admission that could indicate patients who are at a high risk of bacteraemia and who, therefore, merit more intense therapy and stratified care.<\/jats:p>","DOI":"10.3390\/antibiotics9070380","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T03:19:27Z","timestamp":1594005567000},"page":"380","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Martin-Loeches","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Critical Care Medicine, St James\u2019s Hospital, D08 X4RX Dublin, Ireland"},{"name":"Multidisciplinary Intensive Care Research Organization (MICRO), St James\u2019s Hospital, D08 X4RX Dublin, Ireland"},{"name":"Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, CIBERes, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F.R., Marshall, J.C., Finfer, S., Pelosi, P., Brazzi, L., and Aditianingsih, D. (2020). Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA.","DOI":"10.1001\/jama.2020.2717"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Lisboa","year":"2010","journal-title":"Intensive Care Med."},{"key":"ref_3","first-page":"00092\u20132017","article-title":"Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project","volume":"3","author":"Ranzani","year":"2017","journal-title":"ERS Monogr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1473-3099(19)30403-7","article-title":"Ceftolozane\u2013tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial","volume":"19","author":"Kollef","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","first-page":"5","article-title":"Community-acquired pneumonia: identification and evaluation of nonresponders","volume":"1","author":"Conceicao","year":"2013","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/QCO.0000000000000596","article-title":"An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria","volume":"32","author":"Cilloniz","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","article-title":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia","volume":"12","author":"Prina","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/resp.13663","article-title":"Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia","volume":"25","author":"Villafuerte","year":"2020","journal-title":"Respirology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1802406","DOI":"10.1183\/13993003.02406-2018","article-title":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network","volume":"54","author":"Zhou","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201112-2240OC","article-title":"Viral infection in patients with severe pneumonia requiring intensive care unit admission","volume":"186","author":"Choi","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lin, Y.-T., Jeng, Y.-Y., Chen, T.-L., and Fung, C.-P. (2010). Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: Clinical and microbiological characteristics in Taiwan, 2001\u20132008. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-307"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/trstmh\/try022","article-title":"Community-acquired pneumonia and Gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics","volume":"112","author":"Inghammar","year":"2018","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_13","unstructured":"World Health Organization (2019). Disease Burden and Mortality Estimates, WHO."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2007.09.014","article-title":"Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens","volume":"31","author":"Song","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_15","unstructured":"(2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis., 18, 1191\u20131210."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/trstmh\/tru058","article-title":"The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review","volume":"108","author":"Peto","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_17","first-page":"156","article-title":"Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand","volume":"36","author":"Reechaipichitkul","year":"2005","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(04)00931-4","article-title":"Pneumonia in the very old","volume":"4","author":"Janssens","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjopharm.2010.01.003","article-title":"Community-acquired pneumonia in the elderly","volume":"8","author":"Fung","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/17512433.2019.1663730","article-title":"New perspectives in aspiration community acquired Pneumonia","volume":"12","author":"Rodriguez","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cilloniz, C., Dominedo, C., Ielpo, A., Ferrer, M., Gabarrus, A., Battaglini, D., Bermejo-Martin, J., Meli, A., Garcia-Vidal, C., and Liapikou, A. (2019). Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia. J. Clin. Med., 8.","DOI":"10.20944\/preprints201906.0183.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-019-0495-x","article-title":"Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study","volume":"9","author":"Guia","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.resuscitation.2019.11.033","article-title":"Microbiological profile of nosocomial infections following cardiac arrest: Insights from the targeted temperature management (TTM) trial","volume":"148","author":"Harmon","year":"2020","journal-title":"Resuscitation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1097\/01.CCM.0000277042.31524.66","article-title":"Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*","volume":"35","author":"Agbaht","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc10036","article-title":"Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study","volume":"15","author":"Magret","year":"2011","journal-title":"Crit. Care"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lodise, T.P., Bonine, N.G., Ye, J.M., Folse, H.J., and Gillard, P. (2019). Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4363-y"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00134-012-2808-5","article-title":"Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors","volume":"39","author":"Deja","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia","volume":"50","author":"Torres","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.21037\/jtd.2016.12.89","article-title":"Duration of antibiotic therapy in the intensive care unit","volume":"8","author":"Zilahi","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tiszai-Szucs, T., Mac Sweeney, C., Keaveny, J., Bozza, F.A., O Hagan, Z., and Martin-Loeches, I. (2018). Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy. Med. Sci., 6.","DOI":"10.3390\/medsci6020040"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcrc.2018.09.036","article-title":"C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections","volume":"48","author":"Coelho","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcrc.2017.05.007","article-title":"Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study","volume":"41","author":"Povoa","year":"2017","journal-title":"J. Crit. Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s10096-018-3342-3","article-title":"A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems","volume":"37","author":"Kotsaki","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_35","first-page":"193","article-title":"Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: A retrospective 12-year study on 3388 prospectively monitored patients","volume":"28","author":"Stoclin","year":"2020","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MCC.0000000000000124","article-title":"Risks for multidrug-resistant pathogens in the ICU","volume":"20","author":"Diaz","year":"2014","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1701656","DOI":"10.1183\/13993003.01656-2017","article-title":"Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections","volume":"51","author":"Moreau","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10096-015-2495-6","article-title":"COPD patients with ventilator-associated pneumonia: implications for management","volume":"34","author":"Koulenti","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rouze, A., Boddaert, P., Martin-Loeches, I., Povoa, P., Rodriguez, A., Ramdane, N., Salluh, J., Houard, M., and Nseir, S. (2020). Impact of Chronic Obstructive Pulmonary Disease on Incidence, Microbiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections. Microorganisms, 8.","DOI":"10.3390\/microorganisms8020165"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00268-019-05286-3","article-title":"Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients","volume":"44","author":"Younan","year":"2020","journal-title":"World J. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0885066618772498","article-title":"Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome","volume":"35","author":"Zampieri","year":"2018","journal-title":"J. Intensive Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc11312","article-title":"Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy","volume":"16","author":"Forel","year":"2012","journal-title":"Crit. Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-2600(15)00326-4","article-title":"Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study","volume":"3","author":"Povoa","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00134-019-05797-6","article-title":"TAVeM study Group The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection","volume":"45","author":"Torres","year":"2019","journal-title":"Intensive Care Med."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/7\/380\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:35Z","timestamp":1760176055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/9\/7\/380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,5]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["antibiotics9070380"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics9070380","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,5]]}}}